Galderma Group AG (SWX: GALD)
Switzerland
· Delayed Price · Currency is CHF 77.63
-3.07 (-3.80%)
Sep 4, 2024, 9:35 AM CET
Galderma Group AG Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Operating Revenue | 4,281 | 4,082 | 3,760 | 3,417 |
| Other Revenue | 36.8 | 34.8 | 63.6 | 28.1 |
| Revenue | 4,318 | 4,117 | 3,824 | 3,445 |
| Revenue Growth (YoY) | 25.33% | 7.65% | 11.00% | - |
| Cost of Revenue | 1,315 | 1,232 | 1,194 | 1,034 |
| Gross Profit | 3,003 | 2,885 | 2,630 | 2,411 |
| Selling, General & Admin | 2,089 | 1,987 | 1,908 | 1,711 |
| Research & Development | 284.9 | 286.9 | 315.9 | 342.6 |
| Other Operating Expenses | 2.1 | 3.1 | 5.1 | 7.7 |
| Operating Expenses | 2,376 | 2,277 | 2,229 | 2,062 |
| Operating Income | 626.8 | 607.8 | 400.9 | 349.5 |
| Interest Expense | -509.2 | -564.2 | -398.4 | -352.7 |
| Interest & Investment Income | 7.6 | 5.6 | - | - |
| Currency Exchange Gain (Loss) | -34.1 | -29.1 | 4.8 | 72.5 |
| Other Non Operating Income (Expenses) | 47 | 32 | 12.9 | -72.8 |
| EBT Excluding Unusual Items | 138.1 | 52.1 | 20.2 | -3.5 |
| Merger & Restructuring Charges | -17 | -17 | -33.2 | -38 |
| Asset Writedown | 0.4 | -0.6 | -15.2 | -19 |
| Legal Settlements | -16.6 | -23.6 | -23.7 | -19.1 |
| Pretax Income | 104.9 | 10.9 | -51.9 | -79.6 |
| Income Tax Expense | 119.1 | 68.1 | 45 | 4.6 |
| Earnings From Continuing Operations | -14.2 | -57.2 | -96.9 | -84.2 |
| Earnings From Discontinued Operations | - | - | -1.6 | -72 |
| Net Income to Company | -14.2 | -57.2 | -98.5 | -156.2 |
| Minority Interest in Earnings | - | - | - | 1.9 |
| Net Income | -14.2 | -57.2 | -98.5 | -154.3 |
| Net Income to Common | -14.2 | -57.2 | -98.5 | -154.3 |
| Shares Outstanding (Basic) | 5,688 | 5,688 | 5,188 | 5,188 |
| Shares Outstanding (Diluted) | 5,688 | 5,688 | 5,188 | 5,188 |
| Shares Change (YoY) | 9.65% | 9.65% | - | - |
| EPS (Basic) | -0.00 | -0.01 | -0.02 | -0.03 |
| EPS (Diluted) | -0.00 | -0.01 | -0.02 | -0.03 |
| Free Cash Flow | 297.1 | 44.1 | 9.7 | 145.8 |
| Free Cash Flow Per Share | 0.05 | 0.01 | 0.00 | 0.03 |
| Gross Margin | 69.54% | 70.07% | 68.78% | 69.99% |
| Operating Margin | 14.52% | 14.76% | 10.48% | 10.15% |
| Profit Margin | -0.33% | -1.39% | -2.58% | -4.48% |
| Free Cash Flow Margin | 6.88% | 1.07% | 0.25% | 4.23% |
| EBITDA | 841.9 | 820.9 | 630 | 567.3 |
| EBITDA Margin | 19.50% | 19.94% | 16.48% | 16.47% |
| D&A For EBITDA | 215.1 | 213.1 | 229.1 | 217.8 |
| EBIT | 626.8 | 607.8 | 400.9 | 349.5 |
| EBIT Margin | 14.52% | 14.76% | 10.48% | 10.15% |
| Effective Tax Rate | 113.54% | 624.77% | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.